These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3872745)

  • 21. Mechanism for ara-CTP catabolism in human leukemic cells and effect of deaminase inhibitors on this process.
    Fridland A; Verhoef V
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):262-8. PubMed ID: 3035721
    [No Abstract]   [Full Text] [Related]  

  • 22. Adenosine deaminase activity in lymphocytes.
    Sullivan JL; Osborne WR; Wedgewood RJ
    Br J Haematol; 1977 Sep; 37(1):157-8. PubMed ID: 412512
    [No Abstract]   [Full Text] [Related]  

  • 23. Purine degradative enzymes and immunological phenotypes in chronic B-lymphocytic leukaemia: indications that leukaemic immunocytoma is a separate entity.
    Ho AD; Dörken B; Ma DD; Pezzutto A; Hunstein W; Hoffbrand AV
    Br J Haematol; 1986 Mar; 62(3):545-55. PubMed ID: 3006740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum cytidine deaminase as a laboratory test for acute inflammation in rheumatoid arthritis.
    Chalmers IM; Thomson GT; Desjardins P
    Ann Rheum Dis; 1988 Feb; 47(2):173-4. PubMed ID: 3355254
    [No Abstract]   [Full Text] [Related]  

  • 25. Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.
    Tung R; Silber R; Quagliata F; Conklyn M; Gottesman J; Hirschhorn R
    J Clin Invest; 1976 Mar; 57(3):756-61. PubMed ID: 1082452
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adenosine deaminase and purine nucleoside phosphorylase activity in T-and B-lymphocytes of peripheral blood].
    Krizko J; Rendeková V; Niks M; Pechánová E; Pechán I
    Bratisl Lek Listy; 1982 Jul; 78(1):19-26. PubMed ID: 6812861
    [No Abstract]   [Full Text] [Related]  

  • 27. Studies on mechanisms of resistance to cytosine arabinoside: problems in the determination of related enzyme activities in leukemic cells.
    Coleman CN; Johns DG; Chabner BA
    Ann N Y Acad Sci; 1975 Aug; 255():247-51. PubMed ID: 171992
    [No Abstract]   [Full Text] [Related]  

  • 28. [Variation of ratio of adenosine deaminase activity to purine nucleoside phosphorylase activity detected in T-cell leukemic cells].
    Maeda K; Ito K; Yamaguchi N; Sakura N; Usui T
    Rinsho Ketsueki; 1982 Oct; 23(10):1549-54. PubMed ID: 6818390
    [No Abstract]   [Full Text] [Related]  

  • 29. Serum cytidine deaminase assay--some pitfalls.
    Jones DD; Roberts EL; Williams GF
    Br J Obstet Gynaecol; 1986 Apr; 93(4):407-8. PubMed ID: 3964620
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of purine degradative enzymes and terminal deoxynucleotidyl transferase in T cell leukaemias and in normal thymic and post-thymic T cells.
    Ma DD; Massaia M; Sylwestrowicz TA; Price G; Hoffbrand AV
    Br J Haematol; 1983 Jul; 54(3):451-7. PubMed ID: 6305393
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intralymphocytic adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNPase) activity in chronic lymphocytic leukemia (CLL): effect of thymostimulin.
    Petrini M; Bruschi F; Caracciolo F; Carulli G; Grassi B; Ronca-Testoni S; Testi R; Ambrogi F
    Adv Exp Med Biol; 1984; 165 Pt B():327-32. PubMed ID: 6426267
    [No Abstract]   [Full Text] [Related]  

  • 32. Adenosine deaminase and nucleoside phosphorylase activities in normal human blood mononuclear cell subpopulations.
    MacDermott RP; Tritsch GL; Formeister JF
    Clin Exp Immunol; 1980 Nov; 42(2):303-7. PubMed ID: 6781801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Purification and properties of cytidine deaminase from normal and leukemic granulocytes.
    Chabner BA; Johns DG; Coleman CN; Drake JC; Evans WH
    J Clin Invest; 1974 Mar; 53(3):922-31. PubMed ID: 4521417
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of alpha-L-fucosidase activity in normal and chronic-lymphocytic-leukaemia lymphocytes.
    Crockard AD; Bridges JM; Lewis MH
    Biochem Soc Trans; 1980 Aug; 8(4):439-40. PubMed ID: 6969673
    [No Abstract]   [Full Text] [Related]  

  • 35. Biochemical basis for lymphocyte dysfunction in adenosine deaminase and purine nucleoside phosphorylase deficiencies.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Adv Exp Med Biol; 1984; 165 Pt B():133-9. PubMed ID: 6426261
    [No Abstract]   [Full Text] [Related]  

  • 36. Purine nucleoside phosphorylase activity in acute lymphoblastic leukemia.
    Blatt J; Reaman GH; Levin N; Poplack DG
    Blood; 1980 Sep; 56(3):380-2. PubMed ID: 6773605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Adenosine deaminase activity in leukemia patients].
    Müller G; Krug K; Richter V; Krüger W; Rassoul F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):763-8. PubMed ID: 6176499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Remission induction with adenosine-deaminase inhibitor 2'-deoxycoformycin in Thy-lymphoblastic leukaemia.
    Prentice HG; Smyth JF; Ganeshaguru K; Wonke B; Bradstock KF; Janossy G; Goldstone AH; Hoffbrand AV
    Lancet; 1980 Jul; 2(8187):170-2. PubMed ID: 6105339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Adenosine deaminase activity in normal lymphocytes and lymphoproliferative syndromes].
    Corral Alonso M; Gil-Sanz Rodríquez F
    Sangre (Barc); 1983; 28(1):8-18. PubMed ID: 6408747
    [No Abstract]   [Full Text] [Related]  

  • 40. Deoxycytidine transport in the presence of a cytidine deaminase inhibitor and the transport of uracil in Escherichia coli B.
    von Dippe PJ; Leung K; Roy-Burman S; Visser DW
    J Biol Chem; 1975 May; 250(10):3666-71. PubMed ID: 1092677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.